Abstract
In this work we studied the tumor effect of fructose and glucose on the mice xenotransplant model of sarcoma 180 (S180) in in vivo. The experimental results suggest that for dosages of 14 mg/kg and 28 mg/kg glucose (and fructose in a lower rate) show a great inhibitory behavior on tumors.
Keywords: Fructose, glucose, tumors, phenotypes, metabolism, ether, diabetics, tree fruits, melons
Letters in Organic Chemistry
Title: A Comparative Study of Glucose and Fructose in the Development of Sarcoma 180 in Mice
Volume: 8 Issue: 8
Author(s): G. S. Paiva, Carlton A. Taft and Ivone A. de Souza
Affiliation:
Keywords: Fructose, glucose, tumors, phenotypes, metabolism, ether, diabetics, tree fruits, melons
Abstract: In this work we studied the tumor effect of fructose and glucose on the mice xenotransplant model of sarcoma 180 (S180) in in vivo. The experimental results suggest that for dosages of 14 mg/kg and 28 mg/kg glucose (and fructose in a lower rate) show a great inhibitory behavior on tumors.
Export Options
About this article
Cite this article as:
S. Paiva G., A. Taft Carlton and A. de Souza Ivone, A Comparative Study of Glucose and Fructose in the Development of Sarcoma 180 in Mice, Letters in Organic Chemistry 2011; 8 (8) . https://dx.doi.org/10.2174/157017811797249407
DOI https://dx.doi.org/10.2174/157017811797249407 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Primary Cardiac Tumors: A Retrospective Study
Current Respiratory Medicine Reviews A Novel Information Theoretic Approach to Gene Selection for Cancer Classification Using Microarray Data
Current Bioinformatics The use of nanocarriers in acute myeloid leukaemia therapy: challenges and current status.
Current Pharmaceutical Biotechnology Endocrine and Antineoplastic Actions of Growth Hormone-Releasing Hormone Antagonists
Current Medicinal Chemistry Hypoxia-Inducible Factor 1 in Tumor Radioresistance
Current Signal Transduction Therapy Inhibitors of HIV-1 Protease: Current State of the Art 10 Years After their Introduction. From Antiretroviral Drugs to Antifungal, Antibacterial and Antitumor Agents Based on Aspartic Protease Inhibitors
Current Medicinal Chemistry Cutaneous Markers of HIV Infection and Progression
Current HIV Research Antitumour Metallocenes: Structure-Activity Studies and Interactions with Biomolecules.
Current Medicinal Chemistry Vascular Endothelial Growth Factor (VEGF) as a Target of Bevacizumab in Cancer: From the Biology to the Clinic
Current Medicinal Chemistry Epigenetics of Virus-Induced Tumors: Perspectives for Therapeutic Targeting
Current Pharmaceutical Design The State-of-Art in Angiogenic Properties of Latex from Different Plant Species
Current Angiogenesis (Discontinued) Recent Advances in the New Generation Taxane Anticancer Agents
Medicinal Chemistry Current Bioactive Azole-Containing Natural Products
Current Bioactive Compounds Image Guided Biopsy of Musculoskeletal Lesions with Low Diagnostic Yield
Current Medical Imaging Phosphoproteomics: Challenges and Opportunities
Current Proteomics Global Expression Studies of Schizophrenic Brain: A Meta-Analysis Study Linking Neurological Immune System with Psychological Disorders
CNS & Neurological Disorders - Drug Targets Oxidative Stress and Neurodegenerative Diseases: A Neurotrophic Approach
Current Drug Targets SAR, QSAR and Docking of Anticancer Flavonoids and Variants: A Review
Current Topics in Medicinal Chemistry Chemokine Contribution in Stem Cell Engraftment into the Infarcted Myocardium
Current Stem Cell Research & Therapy Tyrosine Kinase Inhibitors
Current Cancer Drug Targets